These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6237560)

  • 21. [Auto-aggressive diseases of the skin].
    Marghescu S
    Wien Med Wochenschr; 1970 Nov; 120(45):779-84. PubMed ID: 4933372
    [No Abstract]   [Full Text] [Related]  

  • 22. A mouse model of lymphocyte infusion-induced bone marrow failure.
    Bloom ML; Wolk AG; Simon-Stoos KL; Bard JS; Chen J; Young NS
    Exp Hematol; 2004 Dec; 32(12):1163-72. PubMed ID: 15588941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome.
    Pullarkat V; Bass RD; Gong JZ; Feinstein DI; Brynes RK
    Am J Hematol; 2003 Jan; 72(1):8-12. PubMed ID: 12508261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Side effects of therapy with antihuman lymphocyte globulin].
    Exadaktylos P; Rumler W; Oppermann J; Grävinghoff J
    Allerg Immunol (Leipz); 1984; 30(3):139-45. PubMed ID: 6239525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunologic and pharmacological principles for the use of immunosuppressive drugs in autoimmune diseases].
    Floersheim GL
    Schweiz Med Wochenschr; 1970 Dec; 100(52):2241-7. PubMed ID: 4946978
    [No Abstract]   [Full Text] [Related]  

  • 26. Refractory immune thrombocytopenia after heart transplantation: a case report.
    Dhar SC; Miller LW
    J Heart Lung Transplant; 1995; 14(4):785-7. PubMed ID: 7578190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A molecular Trojan horse: hijacking the bone marrow to treat autoimmune diseases.
    Alderuccio F; Chan J; Ko HJ; Chung JY; Nasa Z; Toh BH
    Discov Med; 2010 Jun; 9(49):512-8. PubMed ID: 20587340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation between reduced electrophoretic mobility of human lymphocytes and the inhibition of spreading of human monocytes caused by the same anti-human lymphocyte globulin.
    Knippel E; Mazuran R; Preussner S; Schütt W; Silobrcić V
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):413-6. PubMed ID: 6194075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunopathology of New Zealand Black mice treated with antilymphocyte globulin.
    Denman AM; Russell AS; Loewi G; Denman EJ
    Immunology; 1971 Jun; 20(6):973-1000. PubMed ID: 4997578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anaplastic large-cell lymphoma which showed severe inflammatory status and myelodysplasia with increased VEGF and IL-6 serum levels after long-term immunosuppressive therapy.
    Shimamoto T; Hayashi S; Ando K; Yguchi M; Miyazawa K; Kimura Y; Mukai K; Serizawa H; Ohyashiki K
    Am J Hematol; 2001 Jan; 66(1):49-52. PubMed ID: 11426493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of immune glomerular disease.
    Williams DG
    Springer Semin Immunopathol; 1987; 9(4):417-29. PubMed ID: 2963398
    [No Abstract]   [Full Text] [Related]  

  • 32. Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome.
    Schiano TD; Te HS; Thomas RM; Hussain H; Bond K; Black M
    Am J Gastroenterol; 2001 Oct; 96(10):2984-91. PubMed ID: 11693337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
    Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced allograft survival in rhesus monkeys treated with anti-human thymocyte globulin and donor lymphoid cells.
    Thomas JM; Carver FM; Burnett CM; Thomas FT
    Transplant Proc; 1981 Mar; 13(1 Pt 1):599-602. PubMed ID: 7022896
    [No Abstract]   [Full Text] [Related]  

  • 35. [Compatibility of antihuman lymphocyte globulin (AHLG). Possible side effects and complications].
    Preussner S; Frick G; Rudolph W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):37-52. PubMed ID: 88389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant.
    Chen FE; Owen I; Savage D; Roberts I; Apperley J; Goldman JM; Laffan M
    Bone Marrow Transplant; 1997 Mar; 19(5):491-5. PubMed ID: 9052917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A partial conditioning strategy for achieving mixed chimerism in the rat: tacrolimus and anti-lymphocyte serum substantially reduce the minimum radiation dose for engraftment.
    Gammie JS; Li S; Colson YL; Demetris AJ; Neipp M; Ildstad ST; Pham SM
    Exp Hematol; 1998 Sep; 26(10):927-35. PubMed ID: 9728927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental models in the search for new treatments of autoimmune renal diseases.
    Bach MA; Droz D
    Adv Nephrol Necker Hosp; 1980; 9():187-208. PubMed ID: 6773311
    [No Abstract]   [Full Text] [Related]  

  • 40. High-dose lymphoablative therapy (HDLT) with or without autologous stem-cell rescue for treatment of severe autoimmune diseases.
    Tecnologica MAP Suppl; 2001 Dec; ():29-9. PubMed ID: 11933938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.